![Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study - The Lancet ... Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study - The Lancet ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9faba4a-c916-44bd-9dc1-e5b10df466d3/gr1_lrg.jpg)
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study - The Lancet ...
![Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up - European Journal of Surgical Oncology Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up - European Journal of Surgical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119423102/2093628636/gr1.jpg)
Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up - European Journal of Surgical Oncology
![Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm | Nature Reviews Clinical Oncology Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-021-00492-2/MediaObjects/41571_2021_492_Fig1_HTML.png)
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm | Nature Reviews Clinical Oncology
![The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia | American Society of Clinical Oncology Educational Book The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2021/edbk.2021.41/edbk_321247/20210531/images/large/edbk_321247-table2.jpeg)
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia | American Society of Clinical Oncology Educational Book
![Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) - Digestive and Liver Disease Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119489604/2094323417/gr1.jpg)
Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) - Digestive and Liver Disease
![Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-19965-6/MediaObjects/41467_2020_19965_Fig1_HTML.png)
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications
![Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up - Radiotherapy and Oncology Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a16bcecc-cce8-4d03-8038-ae47d6826ad4/gr1_lrg.jpg)
Gastric cancer†: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up - Radiotherapy and Oncology
![Applied Sciences | Free Full-Text | Learning Eligibility in Cancer Clinical Trials Using Deep Neural Networks | HTML Applied Sciences | Free Full-Text | Learning Eligibility in Cancer Clinical Trials Using Deep Neural Networks | HTML](https://www.mdpi.com/applsci/applsci-08-01206/article_deploy/html/images/applsci-08-01206-g001.png)